Abstract:
A cellular communications system end-user transceiver (303) automatically determines (101) at least one received signal strength metric as corresponds to both a presently-utilized base station (307) and at least one presently un-utilized base station (309) to provide one or more corresponding received signal strength values. This transceiver then determines (102) whether to purposefully alter this received signal strength value(s). When deciding to make the alteration, the transceiver automatically alters (104) the received signal strength value(s) to provide one or more corresponding altered signal strength values. The transceiver then transmits (105) the latter in order to influence a handover decision in favor of handing over the transceiver from the presently-utilized base station to the presently un-utilized base station.
Abstract:
The present invention relates to the field of transdermal drug delivery. More specifically, the present invention relates to drug reservoir materials for use in transdermal drug delivery devices. The drug reservoirs of the present invention comprise a polyurethane polymer which can be processed at temperatures below those which cause degradation of temperature sensitive drugs and/or excipients. The present invention is also directed to tailoring the release characteristics of the polyurethane material to accommodate a range of suitable drugs to be delivered from the transdermal drug delivery device and/or provide a range of delivery rates for a particular drug.